local
FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.
Summary by The San Antonio Editorial Desk Matthew Perrone, Associated Press , as published by KSAT 12 (ABC affiliate)
· June 29, 2026
· 1 min read
Photo: KSAT 12 (ABC affiliate) · view original
Story provenance No corrections
Summary created by The San Antonio Editorial Desk — automated, rule-governed Byline on source page Matthew Perrone, Associated Press, as published by KSAT 12 (ABC affiliate) Original story Read at the source Source published Jun 29, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key takeaway Further information on this development can be found through KSAT 12, the local ABC affiliate, which has more details on the upcoming meeting and the FDA's list of experts.
A meeting is set to take place next month where US health officials will reassess a list of peptide drugs that have been a subject of controversy. The Food and Drug Administration has released a list of experts who will be part of the discussion, which includes doctors and pharmacists. These individuals have financial connections to the industry of peptide chemicals, which currently lack proven benefits.
Further information on this development can be found through KSAT 12, the local ABC affiliate, which has more details on the upcoming meeting and the FDA's list of experts.
Why this matters
Local news anchors readers in their community — the people, places, and decisions that shape day-to-day life. The San Antonio covers these stories because national outlets often won't.
About this story
As published by KSAT 12 (ABC affiliate) . The San Antonio surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit KSAT 12 (ABC affiliate) . Have a tip or correction? Contact our newsroom .
Category: local Published: June 29, 2026 Source: KSAT 12 (ABC affiliate) Reading time: 1 min
Frequently asked about this story
What is this story about? A meeting is set to take place next month where US health officials will reassess a list of peptide drugs that have been a subject of controversy. The Food and Drug Administration has released a list…
When was this published? This article was first published on June 29, 2026 by KSAT 12 (ABC affiliate) and curated for The San Antonio readers.
Who reported this story? This story was reported by Matthew Perrone, Associated Press at KSAT 12 (ABC affiliate). To learn more about how The San Antonio selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more local coverage from The San Antonio, or browse our daily briefing and topic hubs .
← Back to all news
More local →
Today’s briefing
Subscribe to newsletter
